Company expands leadership team in preparation for the launch of its AI-driven algorithm for the diagnosis of Parkinson’s Disease.
GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Mr. Albert Garza, MBA will serve as Vice President Commercialization, effective immediately.
Mr. Garza is a veteran of the healthcare industry with a successful record of commercial leadership in equipment, device, and software categories. He brings more than 25 years of experience in product, marketing, and sales functions, domestically and globally, from senior leadership roles with Henry Schein, Solvay, and Dentsply Sirona. His career also includes leadership roles with Amann Girrbach, Discus Dental, and Dell, Inc.
Dr. Martin Handfield, the President and CEO of neuropacs commented: “Mr. Garza is the right leader to guide commercial efforts for neuropacs today. He brings robust healthcare industry experience and know-how to the management team, including expertise in strategic planning, product design, marketing, sales and customer support.” Mr. Garza added: “I am excited to join neuropacs and look forward to collaborating with an outstanding team to bring our innovative solutions to market and help many patients in need.”
For more information about neuropacsTM and its revolutionary diagnostic solutions, visit neuropacs.com.
About neuropacsTM:
neuropacsTM is a pioneering neurological technology company dedicated to developing innovative AI-driven diagnostics. With a commitment to advancing healthcare through cutting-edge technologies, neuropacsTM remains at the forefront of revolutionizing clinical care standards.
Forward-Looking Statements
This communication includes express and implied “forward-looking statements.” Forward-looking statements include all statements that are not historical facts and in some cases, can be identified by terms such as “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “objective,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “ongoing,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. By their nature, these statements are subject to numerous risks and uncertainties, that could cause actual results, performance or achievement to differ materially and adversely from those anticipated or implied in the statements. You should not rely upon forward-looking statements as predictions of future events. Although our management believes that the expectations reflected in our statements are reasonable, we cannot guarantee that the future results, performance, or events and circumstances described in the forward-looking statements will be achieved or occur. Recipients are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date such statements are made and should not be construed as statements of fact. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, any future presentations, or otherwise, except as required by applicable law.